Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 08/02/20161 min de lecture
Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler
Traduction automatique locale · Langue originale de la source
Résumé
This final rule adopts, without change, the interim final rule that was published in the Federal Register on October 27, 2015. The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 milligrams levmetamfetamine) to Aphena Pharma Solutions--New York, LLC. This over- the-counter, nonnarcotic drug product is excluded from the provisions of the Controlled Substances Act.
Langue originale de la source: Federal Register — Justice DepartmentOuvrir le communiqué original →